Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Rockenstein

Showing results (41-50 of 197) with videos related to

Pageof 20
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 7, 2010
Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factorsKiren Ubhi, Edward Rockenstein, Michael Mante, et al.
British Journal of Pharmacology|October 24, 2013
The cannabinoid CB₂ receptor agonist AM1241 enhances neurogenesis in GFAP/Gp120 transgenic mice displaying deficits in neurogenesisHava Karsenty Avraham, Shuxian Jiang, Yigong Fu, et al.
Brain Structure & Function|November 11, 2017
Oligomer-prone E57K-mutant alpha-synuclein exacerbates integration deficit of adult hippocampal newborn neurons in transgenic miceMartin Regensburger, Sebastian R Schreglmann, Svenja Stoll, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 18, 2008
Alpha-synuclein alters Notch-1 expression and neurogenesis in mouse embryonic stem cells and in the hippocampus of transgenic miceLeslie Crews, Hideya Mizuno, Paula Desplats, et al.
The Journal of Biological Chemistry|February 8, 2011
Alpha-synuclein sequesters Dnmt1 from the nucleus: a novel mechanism for epigenetic alterations in Lewy body diseasesPaula Desplats, Brian Spencer, Elizabeth Coffee, et al.
Frontiers in Neuroscience|April 17, 2020
Role of Alterations in Protein Kinase p38γ in the Pathogenesis of the Synaptic Pathology in Dementia With Lewy Bodies and α-Synuclein Transgenic ModelsMichiyo Iba, Changyoun Kim, Jazmin Florio, et al.
BMC Neuroscience|November 28, 2015
Neuroprotective effects of Cerebrolysin in triple repeat Tau transgenic model of Pick's disease and fronto-temporal tauopathiesEdward Rockenstein, Kiren Ubhi, Michael Mante, et al.
Experimental Neurology|December 1, 2009
Lovastatin ameliorates alpha-synuclein accumulation and oxidation in transgenic mouse models of alpha-synucleinopathiesAndrew O Koob, Kiren Ubhi, Johan F Paulsson, et al.
The Journal of Biological Chemistry|July 27, 2007
Enhanced lysosomal pathology caused by beta-synuclein mutants linked to dementia with Lewy bodiesJianshe Wei, Masayo Fujita, Masaaki Nakai, et al.
Journal of Neuroimmunology|December 8, 2004
Patterns of gene dysregulation in the frontal cortex of patients with HIV encephalitisEliezer Masliah, Eleanor S Roberts, Dianne Langford, et al.
Pageof 20

Showing results (41-50 of 197) with videos related to

Sort By:
Pageof 20
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 7, 2010
Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factorsKiren Ubhi, Edward Rockenstein, Michael Mante, et al.
British Journal of Pharmacology|October 24, 2013
The cannabinoid CB₂ receptor agonist AM1241 enhances neurogenesis in GFAP/Gp120 transgenic mice displaying deficits in neurogenesisHava Karsenty Avraham, Shuxian Jiang, Yigong Fu, et al.
Brain Structure & Function|November 11, 2017
Oligomer-prone E57K-mutant alpha-synuclein exacerbates integration deficit of adult hippocampal newborn neurons in transgenic miceMartin Regensburger, Sebastian R Schreglmann, Svenja Stoll, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 18, 2008
Alpha-synuclein alters Notch-1 expression and neurogenesis in mouse embryonic stem cells and in the hippocampus of transgenic miceLeslie Crews, Hideya Mizuno, Paula Desplats, et al.
The Journal of Biological Chemistry|February 8, 2011
Alpha-synuclein sequesters Dnmt1 from the nucleus: a novel mechanism for epigenetic alterations in Lewy body diseasesPaula Desplats, Brian Spencer, Elizabeth Coffee, et al.
Frontiers in Neuroscience|April 17, 2020
Role of Alterations in Protein Kinase p38γ in the Pathogenesis of the Synaptic Pathology in Dementia With Lewy Bodies and α-Synuclein Transgenic ModelsMichiyo Iba, Changyoun Kim, Jazmin Florio, et al.
BMC Neuroscience|November 28, 2015
Neuroprotective effects of Cerebrolysin in triple repeat Tau transgenic model of Pick's disease and fronto-temporal tauopathiesEdward Rockenstein, Kiren Ubhi, Michael Mante, et al.
Experimental Neurology|December 1, 2009
Lovastatin ameliorates alpha-synuclein accumulation and oxidation in transgenic mouse models of alpha-synucleinopathiesAndrew O Koob, Kiren Ubhi, Johan F Paulsson, et al.
The Journal of Biological Chemistry|July 27, 2007
Enhanced lysosomal pathology caused by beta-synuclein mutants linked to dementia with Lewy bodiesJianshe Wei, Masayo Fujita, Masaaki Nakai, et al.
Journal of Neuroimmunology|December 8, 2004
Patterns of gene dysregulation in the frontal cortex of patients with HIV encephalitisEliezer Masliah, Eleanor S Roberts, Dianne Langford, et al.
Pageof 20